Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  American Journal of Respiratory and Critical Care Medicine

• Publication date

  2008-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1164/rccm.200708-1151OCPMID 18263800
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A primer on anaerobic bacteria and anaerobic infections for the uninitiated

  2007cited by this paper
• Exacerbations in cystic fibrosis · 1: Epidemiology and pathogenesis

  2007cited by this paper
• Cystic fibrosis mortality and survival in the UK: 1947–2003

  2007cited by this paper
• Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis

  2007cited by this paper
• Cystic fibrosis: a polymicrobial infectious disease.

  2006cited by this paper
• Are lower airway or throat cultures predictive of sinus bacteriology in cystic fibrosis?

  2006cited by this paper
• Autoaggregation and coaggregation of bacteria associated with acute endodontic infections.

  2006cited by this paper
• 67 Use of anaerobic bacteriological culture for the detection of anaerobic bacteria in sputum from Cystic Fibrosis patients

  2006cited by this paper
• Use of 16S rRNA Gene Profiling by Terminal Restriction Fragment Length Polymorphism Analysis To Compare Bacterial Communities in Sputum and Mouthwash Samples from Patients with Cystic Fibrosis

  2006cited by this paper
• Molecular Characterization of Subject-Specific Oral Microflora during Initial Colonization of Enamel

  2006cited by this paper
• Bronchodilator effect of salbutamol from two different spacer devices

  2006cited by this paper
• Expression of the quorum-sensing regulatory protein LasR is strongly affected by iron and oxygen concentrations in cultures of Pseudomonas aeruginosa irrespective of cell density.

  2005cited by this paper
• Defining the Normal Bacterial Flora of the Oral Cavity

  2005cited by this paper
• The efficacy and safety of meropenem and tobramycin vs ceftazidime and tobramycin in the treatment of acute pulmonary exacerbations in patients with cystic fibrosis.

  2005cited by this paper
• Bacterial activity in cystic fibrosis lung infections

  2005cited by this paper
• Beta-lactamase production and antimicrobial susceptibility of subgingival bacteria from refractory periodontitis.

  2004cited by this paper
• Characterization of Bacterial Community Diversity in Cystic Fibrosis Lung Infections by Use of 16S Ribosomal DNA Terminal Restriction Fragment Length Polymorphism Profiling

  2004cited by this paper
• Molecular (PCR) detection of Pseudomonas spp. other than P. aeruginosa directly from the sputum of adults and children with cystic fibrosis

  2004cited by this paper
• Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria ; Approved Standard — Seventh Edition

  2003cited by this paper
• Colonization of lower respiratory tract with anaerobic bacteria in mechanically ventilated patients

  2003cited by this paper
• Rothia dentocariosa, endocarditis and mycotic aneurysms: case report and review of the literature.

  2003cited by this paper
• Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication

  2003influential reference
• Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients.

  2002cited by this paper
• Three Cases of Rothia dentocariosa Bacteraemia: Frequency in Denmark and a Review

  2002cited by this paper
• Cytokine concentrations and neutrophil elastase activity in bronchoalveolar lavage and induced sputum from patients with cystic fibrosis, mild asthma and healthy volunteers.

  2002cited by this paper
• Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis.

  2002cited by this paper
• New findings in beta-lactam and metronidazole resistant Bacteroides fragilis group.

  2002cited by this paper
• Serum and lower respiratory tract drug concentrations after tobramycin inhalation in young children with cystic fibrosis.

  2001cited by this paper
• Changes in strategies for optimal antibacterial therapy in cystic fibrosis.

  2001cited by this paper
• Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction.

  2001cited by this paper
• Oral microbial communities: biofilms, interactions, and genetic systems.

  2000cited by this paper
• Laboratory diagnosis of anaerobic pleuropulmonary infections.

  2000cited by this paper
• Measurement of proteases in human subgingival dental plaque by fluorescence polarization.

  2000cited by this paper
• Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients.

  1999cited by this paper
• Impact of Microbiology Practice on Cumulative Prevalence of Respiratory Tract Bacteria in Patients with Cystic Fibrosis

  1999cited by this paper
• Development of rRNA-Based PCR Assays for Identification of Burkholderia cepacia Complex Isolates Recovered from Cystic Fibrosis Patients

  1999cited by this paper
• A primer on anaerobic bacteria and anaerobic infections for the uninitiated

  1999cited by this paper
• Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.

  1997cited by this paper
• Use of bronchoalveolar lavage semiquantitative cultures in cystic fibrosis.

  1997cited by this paper
• In vitro activity of quinolones and other antimicrobial agents against anaerobic bacteria.

  1996cited by this paper
• Incidence of anaerobes in ventilator-associated pneumonia with use of a protected specimen brush.

  1996cited by this paper
• Guide to major clinical trials of antiretroviral therapy administered to patients infected with human immunodeficiency virus.

  1996cited by this paper
• "Don't look back--something might be gaining on you".

  1995cited by this paper
• The etiology and antimicrobial susceptibility patterns of microorganisms in acute community-acquired lung abscess.

  1995cited by this paper
• The occurrence, virulence, and antimicrobial resistance of anaerobes in polymicrobial infections.

  1995cited by this paper
• Characterization of immunoglobulin G-degrading proteases of Prevotella intermedia and Prevotella nigrescens.

  1995cited by this paper
• The occurrence, virulence, and antimicrobial resistance of anaerobes in polymicrobial infections

  1995cited by this paper
• The role of encapsulated anaerobic bacteria in synergistic infections.

  1994cited by this paper
• Aerobic and anaerobic microbiology of empyema. A retrospective review in two military hospitals.

  1993cited by this paper
• Lung abscess: analysis of 66 cases from 1979 to 1991.

  1993cited by this paper
• Immunoglobulin A1 (IgA1) proteases from Prevotella (Bacteroides) and Capnocytophaga species in relation to periodontal diseases.

  1991cited by this paper
• The incidence of anaerobes in the sputum of patients with cystic fibrosis.

  1990cited by this paper
• Anaerobic endocarditis caused by Staphylococcus saccharolyticus

  1990cited by this paper
• Direct and indirect pathogenicity of anaerobic bacteria in respiratory tract infections in children.

  1987cited by this paper
• Isolation of capsulate anaerobic bacteria from orofacial abscesses.

  1986cited by this paper
• Cultures of thoracotomy specimens confirm usefulness of sputum cultures in cystic fibrosis.

  1984cited by this paper
• Transtracheal aspiration in pulmonary infection in children with cystic fibrosis.

  1983cited by this paper
• Phagocytosis of Bacteroides melaninogenicus and Bacteroides gingivalis in vitro by human neutrophils.

  1982cited by this paper
• Identifying Rothia dentocariosa.

  1979cited by this paper
• Individual differences in the bacterial flora of the skin of the forehead: Peptococcus saccharolyticus.

  1978cited by this paper
• Epidemiology and Pathogenesis

  year unknowncited by this paper

• Assessing anaerobe detection in routine sputum analyses from cystic fibrosis patients.

  2026cites this paper
• Dual oxic-anoxic co-culture enables direct study of anaerobe–host interactions at the airway epithelial interface

  2025cites this paper
• Airway Microbiome in Children with Cystic Fibrosis: A Review of Microbial Shifts and Therapeutic Impacts

  2025influential citation
• Hyperconcentrated mucus in small airways: a mechanistic model for the pathogenesis of paediatric bronchiectasis

  2025cites this paper
• Metabolic strategies that enable oral commensal persistence in a lower airway environment

  2025cites this paper
• Metabolic Strategies That Enable Oral Commensal Persistence in a Lower Airway Environment

  2025cites this paper
• Exploring heme and iron acquisition strategies of Porphyromonas gingivalis—current facts and hypotheses

  2025cites this paper
• Clinical Disorders in Cystic Fibrosis That Affect Emergency Procedures—A Case Report and Review

  2025cites this paper
• Functional CFTR may be required for Prevotella melaninogenica regulation of epithelial cell defense against Staphylococcus aureus.

  2025cites this paper
• Infections as ecosystems: community metabolic interactions in microbial pathogenesis

  2025cites this paper
• Surface-Exposed Protein Moieties of Burkholderia cenocepacia J2315 in Microaerophilic and Aerobic Conditions

  2024cites this paper
• Clinical relevance of lung microbiota composition in critically ill children with acute lower respiratory tract infections: insights from a retrospective analysis of metagenomic sequencing

  2024cites this paper
• Insights into the Adolescent Cystic Fibrosis Airway Microbiome Using Shotgun Metagenomics

  2024cites this paper
• Air-Pollution-Mediated Microbial Dysbiosis in Health and Disease: Lung–Gut Axis and Beyond

  2024cites this paper
• Genome-scale model of Rothia mucilaginosa predicts gene essentialities and reveals metabolic capabilities

  2024cites this paper
• Practical Guidance for Clinical Microbiology Laboratories: Updated guidance for processing respiratory tract samples from people with cystic fibrosis

  2024cites this paper
• Positioning the preventive potential of microbiome treatments for cystic fibrosis in the context of current therapies.

  2024cites this paper
• Clarithromycin Modulates Neutrophilic Inflammation Induced by Prevotella intermedia in Human Airway Epithelial Cells

  2024cites this paper
• Genomic attributes of airway commensal bacteria and mucosa

  2024cites this paper
• Antibiofilm activity of Prevotella species from the cystic fibrosis lung microbiota against Pseudomonas aeruginosa

  2024cites this paper
• Ectopic colonization by oral bacteria as an emerging theme in health and disease

  2024cites this paper
• Understanding bacterial diversity, infection dynamics, prevention of antibiotic resistance: an integrated study in an Algerian hospital context

  2024cites this paper
• Airway total bacterial density, microbiota community composition and relationship with clinical parameters in bronchiectasis.

  2024cites this paper
• Hemophore-like proteins of the HmuY family in the oral and gut microbiome: unraveling the mystery of their evolution

  2024cites this paper
• Using metabolic potential within the airway microbiome as predictors of clinical state in persons with cystic fibrosis

  2023cites this paper
• ANALYSIS OF MICROBIAL PROFILES IN OBSTRUCTIVE PULMONARY DISEASE AT A TERTIARY CARE HOSPITAL: AN OBSERVATIONAL STUDY

  2023cites this paper
• The first study characterizing the respiratory microbiome in cystic fibrosis patients in Jordan

  2023cites this paper
• P. aeruginosa interactions with other microbes in biofilms during co-infection

  2023cites this paper
• Microbial Epidemiology of the Cystic Fibrosis Airways: Past, Present, and Future

  2023cites this paper
• Bacterial extracellular electron transfer in plant and animal ecosystems.

  2023cites this paper
• Genome-Scale Modeling of Rothia mucilaginosa Reveals Insights into Metabolic Capabilities and Therapeutic Strategies for Cystic Fibrosis

  2023cites this paper
• Chronic airway epithelial hypoxia exacerbates injury in muco-obstructive lung disease through mucus hyperconcentration

  2023cites this paper
• Long-term therapy with elexacaftor/tezacaftor/ivacaftor (ETI) in cystic fibrosis: improved clinical outcomes but infection and inflammation persist

  2023cites this paper
• Therapeutic beta-lactam dosages and broad-spectrum antibiotics are associated with reductions in microbial richness and diversity in persons with cystic fibrosis

  2023cites this paper
• New Phage-Derived Antibacterial Enzyme PolaR Targeting Rothia spp.

  2023cites this paper
• Understanding respiratory microbiome–immune system interactions in health and disease

  2023cites this paper
• Dietary phytochemicals, gut microbiota composition, and health outcomes in human and animal models

  2023cites this paper
• Inflammation and Infection in Cystic Fibrosis: Update for the Clinician

  2022cites this paper
• Inflammation-associated nitrate facilitates ectopic colonization of oral bacterium Veillonella parvula in the intestine

  2022cites this paper
• In host evolution of Exophiala dermatitidis in cystic fibrosis lung micro-environment

  2022cites this paper
• Opportunistic Pathogens in Cystic Fibrosis: Epidemiology and Pathogenesis of Lung Infection.

  2022cites this paper
• Supplemental Oxygen Alters the Airway Microbiome in Cystic Fibrosis

  2022cites this paper
• Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases.

  2022cites this paper
• Complex and unexpected outcomes of antibiotic therapy against a polymicrobial infection

  2022cites this paper
• Porphyromonas pasteri and Prevotella nanceiensis in the sputum microbiota are associated with increased decline in lung function in individuals with cystic fibrosis

  2022cites this paper
• Immunometabolism in biofilm infection: lessons from cancer

  2022cites this paper
• Relationships Between Oral Microecosystem and Respiratory Diseases

  2022cites this paper
• Physiology and Pathophysiology of Human Airway Mucus.

  2022cites this paper
• Changes in Microbiome Dominance Are Associated With Declining Lung Function and Fluctuating Inflammation in People With Cystic Fibrosis

  2022cites this paper
• Genomic diversity and antimicrobial resistance of Prevotella species isolated from chronic lung disease airways

  2022cites this paper
• Exploring the Cystic Fibrosis Lung Microbiome: Making the Most of a Sticky Situation

  2022cites this paper
• Cystic Fibrosis Airway Mucus Hyperconcentration Produces a Vicious Cycle of Mucin, Pathogen, and Inflammatory Interactions that Promote Disease Persistence.

  2022cites this paper
• The changing landscape of the cystic fibrosis lung environment: From the perspective of Pseudomonas aeruginosa.

  2022cites this paper
• Prevotella melaninogenica, a Sentinel Species of Antibiotic Resistance in Cystic Fibrosis Respiratory Niche?

  2021influential citation
• Antibiotics Drive Expansion of Rare Pathogens in a Chronic Infection Microbiome Model

  2021cites this paper
• The respiratory microbiome and nontuberculous mycobacteria: an emerging concern in human health

  2021cites this paper
• Integrative microbiomics in bronchiectasis exacerbations

  2021cites this paper
• Biofilm Formation on Dental Implant Biomaterials by Staphylococcus aureus Strains Isolated from Patients with Cystic Fibrosis

  2021cites this paper
• Polymicrobial Interactions in the Cystic Fibrosis Airway Microbiome Impact the Antimicrobial Susceptibility of Pseudomonas aeruginosa

  2021cites this paper
• An observational study of anaerobic bacteria in cystic fibrosis lung using culture dependant and independent approaches

  2021cites this paper
• Therapeutic peptides for the treatment of cystic fibrosis: Challenges and perspectives.

  2021cites this paper
• Systems Biology and Bile Acid Signalling in Microbiome-Host Interactions in the Cystic Fibrosis Lung

  2021cites this paper
• In vivo pharmacodynamics of lascufloxacin and levofloxacin against Streptococcus pneumoniae and Prevotella intermedia in a pneumonia mixed-infection mouse model.

  2021cites this paper
• Outcomes of cystic fibrosis pulmonary exacerbations treated with antibiotics with activity against anaerobic bacteria.

  2021cites this paper
• Relationship between airway dysbiosis, inflammation and lung function in adults with cystic fibrosis.

  2021cites this paper
• Comparison of the airway microbiota in children with chronic suppurative lung disease

  2021cites this paper
• Multi-Omics Study of Keystone Species in a Cystic Fibrosis Microbiome

  2021cites this paper
• Rothia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease

  2021cites this paper
• Effect of Low Amperage Electric Current on Staphylococcus Aureus—Strategy for Combating Bacterial Biofilms Formation on Dental Implants in Cystic Fibrosis Patients, In Vitro Study

  2021cites this paper
• Primary Sclerosing Cholangitis

  2021cites this paper
• Anaerobic microbiota facilitate P. aeruginosa access to the airway epithelium in a novel co-culture model of colonization

  2021cites this paper
• Impact of Anaerobic Antibacterial Spectrum on Cystic Fibrosis Airway Microbiome Diversity and Pulmonary Function

  2021cites this paper
• Genomic diversity and antimicrobial resistance of Prevotella spp. isolated from chronic lung disease airways

  2021cites this paper
• Dynamics of Respiratory Microbiome Profiles Contributes to Imbalance and Lung Dysbiosis in the Respiratory Tract

  2021cites this paper
• Mucolytic bacteria: prevalence in various pathological diseases

  2021cites this paper
• Periodontal condition and periodontal risk assessment in adult patients with cystic fibrosis.

  2020influential citation
• Microbial interaction: Prevotella spp. reduce P. aeruginosa induced inflammation in cystic fibrosis bronchial epithelial cells.

  2020cites this paper
• Burn- and Trauma-Associated Pulmonary Infection

  2020cites this paper
• Recent advances in DNA gyrase-targeted antimicrobial agents.

  2020cites this paper
• Toll like Receptor signalling by Prevotella histicola activates alternative NF-κB signalling in Cystic Fibrosis bronchial epithelial cells compared to P.aeruginosa

  2020cites this paper
• The histone-like protein AlgP regulon is distinct in mucoid and nonmucoid Pseudomonas aeruginosa and does not include alginate biosynthesis genes.

  2020cites this paper
• Bacterial Infections and the Respiratory Microbiome

  2020cites this paper
• Contribution of Short Chain Fatty Acids to the Growth of Pseudomonas aeruginosa in Rhinosinusitis

  2020cites this paper
• Metagenomic Analysis of the Lung Microbiome in Chemically Injured and Healthy Individuals

  2020cites this paper
• Culture-enriched metagenomic sequencing enables in-depth profiling of the cystic fibrosis lung microbiota

  2020cites this paper
• Acute and Chronic Infection Management in CF

  2020cites this paper
• The clinical and microbiological utility of inhaled aztreonam lysine for the treatment of acute pulmonary exacerbations of cystic fibrosis: An open-label randomised crossover study (AZTEC-CF).

  2020cites this paper
• Bronchoalveolar Lavage: Microbial Evaluation

  2020cites this paper
• Metagenomic Next-Generation Sequencing of Nasopharyngeal Specimens Collected from Confirmed and Suspect COVID-19 Patients

  2020cites this paper
• Ecological Succession of Polymicrobial Communities in the Cystic Fibrosis Airways

  2020cites this paper
• Comprehensive evaluation of complex polymicrobial specimens using next generation sequencing and standard microbiological culture

  2020cites this paper
• Bronchial Mucus: Basic research and clinical application

  2020cites this paper
• LC-MS detection of antibiotic agents in sputum from persons with cystic fibrosis.

  2020cites this paper
• Strain-Resolved Dynamics of the Lung Microbiome in Patients with Cystic Fibrosis

  2020cites this paper
• Toll like Receptor signalling by Prevotella histicola activates alternative 2 NF-κB signalling in Cystic Fibrosis bronchial epithelial cells compared to 3 P . aeruginosa 4 5

  2020cites this paper
• Recent Approach in Microbial Pathogen Complications in Patients with Cystic Fibrosis

  2020cites this paper
• TLR5 signalling activates the alternative NF-κB signalling pathway in Cystic Fibrosis bronchial epithelial cells in response to infection with Prevotella histicola.

  2020cites this paper
• The airway microbiome in COPD, bronchiectasis and bronchiectasis‐COPD overlap

  2020cites this paper
• Antibiotic susceptibility of cystic fibrosis lung microbiome members in a multispecies biofilm

  2020cites this paper
• Potential Contributions of Anaerobes in Cystic Fibrosis Airways

  2020cites this paper